Life Science News and Press Releases

Population Genetics launches funding award for novel population sequencing studies

Population Genetics Technologies

15/10/2012

The Populus Award 2012 offers financial and expert practical support for the completion of a multi-sample gene sequencing project using Population Genetics’ proprietary technologies.Cambridge, UK – 15th October, 2012 – Population Genetics Technologies Ltd., a company dedicated to the development of innovative approaches for genetic analyses and biomarker discovery, has today launched the Populus Award 2012. Inviting abstracts from researchers...

OGT to discuss the latest genomic tools for cytogeneticists at AMP and ASHG 2012

Oxford Gene Technology

15/10/2012

Enhanced analysis using CytoSure™ arrays for simultaneous aCGH and SNP detectionOxford, UK – 15 October 2012. Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, will be hosting booths at two key US cytogenetics meetings over the next few weeks. The first is the Association for Molecular Pathology (AMP) Annual Meeting on Genomic Medicine 2012 to be held in Long Beach, CA (25-27...

IDT’s gBlocks™ Gene Fragments Used to Investigate Biology of the Immune Response

Integrated DNA Technologies

11/10/2012

The latest DECODED newsletter discusses an exciting synthetic biology case studyCORALVILLE, IA – 11 October 2012 – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, has released the latest issue of DECODED. This quarter’s edition describes the research of Dr Vigneault (Church Laboratory, Harvard Medical School), and the lab’s use of IDT gBlocks™ Gene Fragments to study the biology of how patients respond to...

SDIX Genomic Antibody Technology

SDIX

09/10/2012

SDIX is hosting a series of webinars this fall: Design & Development of Successful Antibodies to Complex Targets. Overview: While the requirement for better antibodies has grown exponentially in recent years, the ability to develop these antibodies has lagged behind this need. At SDIX, a focus on the philosophy of better antigen design has resulted in dramatic improvements to the antibody production process.In a series of talks, SDIX scientists will discuss...

New evidence-based 3D cell culture web portal launched by Reinnervate Ltd

Reinnervate

09/10/2012

Sedgefield, UK. October 2012 – Reinnervate Ltd, the developers of Alvetex®Scaffold for 3D cell culture, today announced the launch of a new 3D cell culture portal for scientists in the life science sector. The new resource brings together a wide variety of information, protocols, peer-reviewed papers and videos to help not only those who are considering the adoption of 3D cell culture but also those already using this approach to growing cells in...

ibidi’s µ-Slides are as Efective as Glass Slides in Live Cell Super-Resolution Microscopy

ibidi GmbH

08/10/2012

Munich, Germany, October 8, 2012 - ibidi GmbH, a supplier of products used for analyzing living cells, is now providing solutions for Super-Resolution Microscopy.Recent research articles show that ibidi’s µ-Slides, which have a special plastic bottom, are perfectly suited for super-resolution imaging applications based on the novel microscopy method, (d)STORM. ibidi’s standard surface, which forms the bottom of most ibidi µ-Slides and...

BD launches new Safety Blood Collection Needle with flashback chamber

BD (Becton, Dickinson and Company)

04/10/2012

Intuitive, easy-to-use, single-handed activation device combines safety with added reassurance of flashback for the confidence of successOxford, UK (04 October 2012) – BD (Becton, Dickinson and Company), a leading global medical technology company, announces the launch of the new BD Vacutainer® Eclipse™ Signal™ Blood Collection Needle in Europe. The safety-engineered design with single-handed activation, integrated holder and a new flashback chamber...

New Assay Rapidly Identifies Lethal Pathogen Responsible for Clostridium difficile Infection

BD (Becton, Dickinson and Company)

02/10/2012

BD MAX™ Cdiff Test Launches in Europe, Expanding HAI Portfolio on BD MAX™ SystemBaltimore, MD (02 October 2012) – BD Diagnostics, a segment of BD (Becton, Dickinson and Company), today announced that it obtained CE Marking of the BD MAX™ Cdiff Assay. The assay detects the toxin B gene (tcdB), which has been shown to be present in all toxigenic C. difficile and is essential for disease.Run on the fully automated BD MAX™ System, the assay is...